Jose Raul MEDINA-LÓPEZ, Alexander Domínguez-Reyes, Marcela Hurtado
{"title":"用USP仪器2和4进行速尿非专利产品体外释放研究的比较","authors":"Jose Raul MEDINA-LÓPEZ, Alexander Domínguez-Reyes, Marcela Hurtado","doi":"10.14227/DT280121P14","DOIUrl":null,"url":null,"abstract":"Dissolution studies are essential for comparing the quality of generic drugs to their reference products. The objective of this work was to evaluate the in vitro release of furosemide in tablets under official dissolution conditions and using the flow-through cell method. To this end, two USP apparatus were used: apparatus 2 (paddle at 50 rpm) containing 900 mL of phosphate buffer solution pH 5.8, and apparatus 4 (flow-through cell at 16 mL/min) with the same medium. The dissolved drug was quantified by UV spectrophotometry at 274 nm for 60 min. Although the results at a single time point met the acceptance criterion of Q = 80% at 60 min, the dissolution profiles of generic drugs were not similar to the reference product. The similarity factor (f2 < 50), mean dissolution time, dissolution efficiency, t50%, t80%, and Td values corroborate the difference between the profiles (p < 0.05). In vitro release testing demonstrates that, for furosemide tablets available in Mexico, the generic formulations perform differently from the reference products. These differences could affect in vivo absorption, which could yield different therapeutic effects. More evaluation of generic furosemide tablets manufactured in Mexico is needed.","PeriodicalId":11380,"journal":{"name":"Dissolution Technologies","volume":"28 1","pages":"14-22"},"PeriodicalIF":1.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Comparison of Generic Furosemide Products by In Vitro Release Studies using USP Apparatus 2 and 4\",\"authors\":\"Jose Raul MEDINA-LÓPEZ, Alexander Domínguez-Reyes, Marcela Hurtado\",\"doi\":\"10.14227/DT280121P14\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Dissolution studies are essential for comparing the quality of generic drugs to their reference products. The objective of this work was to evaluate the in vitro release of furosemide in tablets under official dissolution conditions and using the flow-through cell method. To this end, two USP apparatus were used: apparatus 2 (paddle at 50 rpm) containing 900 mL of phosphate buffer solution pH 5.8, and apparatus 4 (flow-through cell at 16 mL/min) with the same medium. The dissolved drug was quantified by UV spectrophotometry at 274 nm for 60 min. Although the results at a single time point met the acceptance criterion of Q = 80% at 60 min, the dissolution profiles of generic drugs were not similar to the reference product. The similarity factor (f2 < 50), mean dissolution time, dissolution efficiency, t50%, t80%, and Td values corroborate the difference between the profiles (p < 0.05). In vitro release testing demonstrates that, for furosemide tablets available in Mexico, the generic formulations perform differently from the reference products. These differences could affect in vivo absorption, which could yield different therapeutic effects. More evaluation of generic furosemide tablets manufactured in Mexico is needed.\",\"PeriodicalId\":11380,\"journal\":{\"name\":\"Dissolution Technologies\",\"volume\":\"28 1\",\"pages\":\"14-22\"},\"PeriodicalIF\":1.0000,\"publicationDate\":\"2021-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Dissolution Technologies\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.14227/DT280121P14\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Dissolution Technologies","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.14227/DT280121P14","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
Comparison of Generic Furosemide Products by In Vitro Release Studies using USP Apparatus 2 and 4
Dissolution studies are essential for comparing the quality of generic drugs to their reference products. The objective of this work was to evaluate the in vitro release of furosemide in tablets under official dissolution conditions and using the flow-through cell method. To this end, two USP apparatus were used: apparatus 2 (paddle at 50 rpm) containing 900 mL of phosphate buffer solution pH 5.8, and apparatus 4 (flow-through cell at 16 mL/min) with the same medium. The dissolved drug was quantified by UV spectrophotometry at 274 nm for 60 min. Although the results at a single time point met the acceptance criterion of Q = 80% at 60 min, the dissolution profiles of generic drugs were not similar to the reference product. The similarity factor (f2 < 50), mean dissolution time, dissolution efficiency, t50%, t80%, and Td values corroborate the difference between the profiles (p < 0.05). In vitro release testing demonstrates that, for furosemide tablets available in Mexico, the generic formulations perform differently from the reference products. These differences could affect in vivo absorption, which could yield different therapeutic effects. More evaluation of generic furosemide tablets manufactured in Mexico is needed.
期刊介绍:
Dissolution Technologies is a peer reviewed quarterly
publication reporting ongoing, useful information on
dissolution testing of pharmaceuticals. It provides an
international forum for dissolution analysts to receive
and exchange information on various dissolution topics.
Dissolution Technologies welcomes submissions related
to dissolution, in vitro release, and disintegration testing.
These topics should be the major focus of the article.
Do not submit articles where the focus is formulation
development with dissolution testing as one of many
tests.